EUVIMEDEUVIMED entdecken
Crossref

Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer

Yoshiaki Nagatani, Naomi Kiyota, Yoshinori Imamura, Taiji Koyama, Yohei Funakoshi, Masato Komatsu, Tomoo Itoh, Masanori Teshima, Ken-Ichi Nibu, Kazuko Sakai, Kazuto Nishio, Manami Shimomura und 5 weitere

Asia-Pacific Journal of Clinical Oncology · 2024

DOI: 10.1111/ajco.14108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2024. Verfasst von Yoshiaki Nagatani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Grant-in-Aid for Scientific Research C, Ministry of Education, Culture, Sports, Science and Technology, Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Although immune checkpoint inhibitors (ICPi) for salivary gland cancer (SGC) have been investigated in clinical trials, details of the tumor immune microenvironment (TIME) remain unclear. This research aimed to elucidate the TIME of SGC and its relationship with tumor mutation burden (TMB) and to explore the rationale for the applicability of ICPi. Materials and methods We selected five pathological types, namely adenoid cystic carcinoma (ACC); adenocarcinoma, not otherwise specified (ANOS); salivary duct carcinoma (SDC); and low/high‐grade mucoepidermoid carcinoma (MEC low/high ). We investigated the TIME and TMB of each pathological type. TIME was evaluated by multiplexed fluorescent immunohistochemistry. TMB was measured by next‐generation sequencing.

Results

ACC and MEC high showed the lowest and highest infiltration of immune effector and suppressor cells in both tumor and stroma. ANOS, SDC, and MEC low showed modest infiltration of immune effector cells in tumors. Correlation analysis showed a positive correlation between CD3 + CD8 + T cells in tumor and TMB ( r = 0.647). CD3 + CD8 + T cells in tumors showed a positive correlation with programmed cell death‐ligand 1 expression in tumor cells ( r = 0.513) and a weak positive correlation with CD3 + CD4 + Foxp3 + cells in tumors ( r = 0.399). However, no correlation was observed between CD3 + CD8 + T cells and CD204 + cells in tumors ( r = ‐0.049).

Conclusion

The TIME of ACC was the so‐called immune desert type, which may explain the mechanisms of the poor response to ICPi in previous clinical trials. On the other hand, MEC high was the immune‐inflamed type, and this may support the rationale of ICPi for this pathological subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salivary Gland NeoplasmsTumor MicroenvironmentHumansMaleCarcinoma, Adenoid CysticFemaleMiddle AgedCarcinoma, MucoepidermoidAgedBiomarkers, TumorMutationImmune Checkpoint Inhibitors

Stichwörter der Autor:innen

immune checkpoint inhibitormultiplexed fluorescent immunohistochemistrysalivary gland cancertumor immune microenvironmenttumor mutation burden

Substanzen

Biomarkers, TumorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Kobe University Hospital Cancer Center, Kobe, Japan.
  • Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Department of Genome Biology, Kindai University Faculty of Medicine, Sayama, Japan.
  • Division of Cancer Immunotherapy (Kashiwa), Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.

Förderung

  • Grant-in-Aid for Scientific Research C
  • Ministry of Education, Culture, Sports, Science and Technology, Japan

Zitieren

APA

Nagatani, Y., Kiyota, N., Imamura, Y., Koyama, T., Funakoshi, Y., Komatsu, M., Itoh, T., Teshima, M., Nibu, K. I., Sakai, K., Nishio, K., Shimomura, M., Nakatsura, T., Ikarashi, D., Nakayama, T., Kitano, S., & Minami, H. (2024). Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.14108

Vancouver

Nagatani Y, Kiyota N, Imamura Y, Koyama T, Funakoshi Y, Komatsu M, et al. Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer. Asia-Pacific Journal of Clinical Oncology. 2024. doi:10.1111/ajco.14108

BibTeX
@article{Nagatani2024,
  author = {Nagatani, Yoshiaki and Kiyota, Naomi and Imamura, Yoshinori and Koyama, Taiji and Funakoshi, Yohei and Komatsu, Masato and Itoh, Tomoo and Teshima, Masanori and Nibu, Ken-Ichi and Sakai, Kazuko and Nishio, Kazuto and Shimomura, Manami and Nakatsura, Tetsuya and Ikarashi, Daiki and Nakayama, Takayuki and Kitano, Shigehisa and Minami, Hironobu},
  title = {Different characteristics of the tumor immune microenvironment among subtypes of salivary gland cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1111/ajco.14108}
}
Kostenlos starten →